Company · CIK 0001367644 · SIC 2834 — Pharmaceutical Preparations · NYSE
Emergent BioSolutions Inc. · EBS
Insider activity reported against this company. All insider holders · Files at: APVO. On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 SForm 4 → | Jul 2, 12:57 pm EDT | Paul Anthony WilliamsSVP, Products Business | 3,000 | $8.40 | $25,200 | 159,098 | −1.85% | 10b5-1 |
| Jun 8, 2026 FForm 4 → | Jun 10, 3:09 pm EDT | Paul Anthony WilliamsSVP, Products Business | 694 | $8.00 | $5,552 | 162,098 | — | |
| Jun 8, 2026 FForm 4 → | Jun 10, 3:08 pm EDT | Richard S LindahlEVP, Chief Financial Officer | 3,964 | $8.00 | $31,712 | 374,083 | — | |
| Jun 8, 2026 FForm 4 → | Jun 10, 3:07 pm EDT | Coleen GlessnerEVP, Quality & Ethics, and CPL | 2,018 | $8.00 | $16,144 | 202,201 | — | |
| Jun 8, 2026 FForm 4 → | Jun 10, 3:05 pm EDT | William HartzelSVP, Bioservices | 1,741 | $8.00 | $13,928 | 185,558 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.
Filed by this entity as an insider elsewhere — common stock
No reported common-stock activity in this period.
Filed by this entity as an insider elsewhere — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.